» Articles » PMID: 19695865

Clinical Features and Colorectal Cancer Survival: an Attempt to Explain Differences Between Two Different Italian Regions

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2009 Aug 22
PMID 19695865
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: AIMS OF THE STUDY AND METHODS: Recent studies suggested the existence of significant regional variations, in Italy, for cancer survival. For most neoplasms, survival rates tended to be lower in Southern regions versus Northern areas; for colorectal tumours, 5-year survival was 60% in Northern regions, but ranged between 40% and 50% in the South. Main purpose of the present study was to find out possible reasons which might explain such differences. To reach this objective, we compared the main epidemiological and clinical data in two areas covered by cancer registration: Modena, in the North, and Naples in the South of Italy.

Results: The results of the study suggest that differences in colorectal cancer survival can be mainly attributed to a different stage at diagnosis, which was less favourable in a larger fraction of cases diagnosed in Southern Italy. This could be the consequence of an insufficient diffusion of screening procedures. Type of surgery, medical treatment and follow-up seem to play little or no role. The study also shows that incidence rates of colorectal cancer are significantly higher in the North than in the South of the country, and that the excess of cases seen in Modena is limited to the age group 55-75+ years, while age-specific incidence is virtually identical in the younger age classes.

Conclusion: This high-resolution study confirms the paramount importance of stage at diagnosis in the management of colorectal cancer, and suggests that social and economic factors are of relevance, even in Western countries, for reducing inequalities in cancer care.

Citing Articles

A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries.

Alsadhan N, Almaiman A, Pujades-Rodriguez M, Brennan C, Shuweihdi F, Alhurishi S BMC Med Res Methodol. 2022; 22(1):144.

PMID: 35590277 PMC: 9118801. DOI: 10.1186/s12874-022-01632-7.


Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Sinding C, Warren R, Fitzpatrick-Lewis D, Sussman J Support Care Cancer. 2014; 22(11):3101-20.

PMID: 25120008 DOI: 10.1007/s00520-014-2348-3.


MicroRNA target prediction: theory and practice.

Wagner M, Vicinus B, Frick V, Auchtor M, Rubie C, Jeanmonod P Mol Genet Genomics. 2014; 289(6):1085-101.

PMID: 24938624 DOI: 10.1007/s00438-014-0871-z.


Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network.

Pizzi C, Arpino G, Acampora G, Aiello N, DE Rosa A, Diaferia I Mol Clin Oncol. 2014; 1(4):726-732.

PMID: 24649236 PMC: 3915682. DOI: 10.3892/mco.2013.101.


Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone.

Cavalli-Bjorkman N, Qvortrup C, Sebjornsen S, Pfeiffer P, Wentzel-Larsen T, Glimelius B Br J Cancer. 2012; 107(1):189-94.

PMID: 22576591 PMC: 3389401. DOI: 10.1038/bjc.2012.186.